PMID: 6538013Feb 1, 1984Paper

Effect of alcohol on tremors: comparison with propranolol

Neurology
W C Koller, N Biary

Abstract

Intravenous administration of alcohol decreased postural essential tremor but not parkinsonian resting or cerebellar intention tremor. The response to alcohol infusion occurred in all 15 patients studied, whereas only 11 of the 15 had a response to propranolol therapy. Furthermore, the response to ethanol was greater than that due to propranolol.

Citations

Aug 6, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·H WilmsG Deuschl
Jun 1, 1995·Biofeedback and Self-regulation·W ChungD A Lundervold
Mar 30, 2006·Current Treatment Options in Neurology·William G Ondo
May 20, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Fatta B NahabMark Hallett
Mar 29, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Fatta B NahabMark Hallett
Jul 20, 2000·Parkinsonism & Related Disorders·I Milanov
Nov 23, 2006·Nature Clinical Practice. Neurology·Julián Benito-León, Elan D Louis
Mar 1, 2002·The New England Journal of Medicine·Stanley van den Noort
Jun 1, 1991·Alcoholism, Clinical and Experimental Research·L A Pohorecky
Jun 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·T KachiC D Marsden
Feb 1, 1986·Journal of Neurology, Neurosurgery, and Psychiatry·H TeräväinenP Lewitt
Dec 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·N BiaryP Langenberg
Nov 29, 2007·Neuroepidemiology·Nikolaos Scarmeas, Elan D Louis
Nov 18, 2010·Drugs·Reza Sadeghi, William G Ondo
Mar 1, 1995·Chaos·John Milton, Deborah Black
Apr 1, 1990·Reviews in the Neurosciences·S Fahn
Sep 18, 2004·Journal of the American Pharmacists Association : JAPhA·Peter J Ambrose
Jun 7, 2011·Neuropharmacology·Pervin K IseriNurbay Ates
Sep 27, 2006·Clinics in Geriatric Medicine·Elan D Louis
Dec 8, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Fredricka C MartinAdrian Handforth
Nov 26, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Kirsten E ZeunerMark Hallett
May 11, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Elan D LouisMichael Parides
Feb 1, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Calvin MelmedHoward Rutman
Oct 25, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Karina KnudsenGünther Deuschl
Aug 20, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Giovanni Mostile, Joseph Jankovic
Jan 25, 2005·Lancet Neurology·Elan D Louis
Oct 20, 2006·Journal of the Neurological Sciences·K M PrakashE K Tan
Jan 1, 1987·Movement Disorders : Official Journal of the Movement Disorder Society·N Biary, W C Koller
Aug 2, 2003·The American Journal of Medicine·Rajesh Pahwa, Kelly E Lyons
May 24, 2015·Parkinsonism & Related Disorders·Franziska HopfnerGregor Kuhlenbäumer
Dec 13, 2016·Clinical Neuropharmacology·Federico MicheliMichel Saenz-Farret
Jul 1, 2009·Therapeutic Advances in Neurological Disorders·Alexandre Gironell, Jaime Kulisevsky
Oct 1, 1999·Addiction Biology·M Gutgesell, R Canterbury
May 9, 2014·Journal of Central Nervous System Disease·Ali H Rajput, Alex Rajput
Jan 27, 2007·The Cochrane Database of Systematic Reviews·R J MillsC A Young
Jan 25, 2020·Current Neuropharmacology·Hortensia Alonso-NavarroFélix J Jiménez-Jiménez
Apr 7, 2017·Therapeutic Advances in Neurological Disorders·Peter Hedera
Nov 25, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·P G WasielewskiW C Koller
Nov 25, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·H Boecker, D J Brooks
Mar 30, 2005·Expert Opinion on Pharmacotherapy·Courtney R SchadtP David Charles
Sep 1, 2004·The Neurologist·Kelly L SullivanTheresa A Zesiewicz
May 5, 2018·Frontiers in Neurology·Jean-Francois Daneault
Jan 20, 2021·Parkinsonism & Related Disorders·Stela Santos de AlencarVitor Tumas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.